序号 |
标题 |
次数 |
作者 |
发布时间 |
82576 |
94885-04-8,C6NBD-神经鞘氨酯,C6 NBD Sphingomyelin (d18:1/6:0) |
111 |
kx |
2024-11-29 |
82577 |
降冰片烯二酸酐(XMNA) |
266 |
h |
2024-11-29 |
82578 |
5-降冰片烯-2,3-二羧酸二甲酯(DCNM) |
139 |
h |
2024-11-29 |
82579 |
5-降冰片烯-2-亚甲基-(6-溴己基)醚(NB-O-Br) |
150 |
h |
2024-11-29 |
82580 |
N-环庚基降冰片烯酰亚胺(CHepNDI) |
111 |
h |
2024-11-29 |
82581 |
5-降冰片烯-2-甲醇(NB-CH2OH) |
143 |
h |
2024-11-29 |
82582 |
Tz-BODIPY-MOR;氟化硼二吡咯-四嗪靶向溶酶体 |
135 |
|
2024-11-29 |
82583 |
5-降冰片烯-2-甲醛 |
135 |
h |
2024-11-29 |
82584 |
侧链双键的降冰片烯衍生物(ENB) |
203 |
h |
2024-11-29 |
82585 |
降冰片烯基三氟乙酯(NF) |
209 |
h |
2024-11-29 |
82586 |
2375774-54-0,Pomalidomide-C6-O-C5-O-C4-COOH |
133 |
kx |
2024-11-29 |
82587 |
3,6-二-2-吡啶基-1,2,4,5-四嗪 |
133 |
WYQ |
2024-11-29 |
82588 |
钯芳基降冰片烯五元环(ANP) |
150 |
h |
2024-11-29 |
82589 |
(2-氨基乙基)-吗啉基团偶联3-(吡啶-3-基)-6-氨基乙基-1,2,4,5-四嗪偶联(LysoTz) |
121 |
WYQ |
2024-11-29 |
82590 |
降冰片烯羧酸甲酯聚合物(P(exo-MeNB) |
106 |
h |
2024-11-29 |
82591 |
1578249-76-9,Mal-C6-α-Amanitin |
88 |
kx |
2024-11-29 |
82592 |
降冰片烯二酸酐-马来酰亚胺基七异丁基聚倍半硅氧烷交替共聚物 poly(MIPOSS-alt-NA) |
303 |
h |
2024-11-29 |
82593 |
5-丁氧基亚甲基-2-降冰片烯,双-(β-酮萘胺)镍(Ⅱ)/B(C6F5)3 |
124 |
h |
2024-11-29 |
82594 |
CAS:2921619-48-7;DOTA-方酸-PEG4(丙酸)-ONCOFAP |
162 |
zcy |
2024-11-29 |
82595 |
萘酰亚胺修饰聚降冰片烯共聚物P-NB-NA-PEG |
94 |
h |
2024-11-29 |
82596 |
聚乙叉降冰片烯二乙烯基联苯共聚物 |
158 |
h |
2024-11-29 |
82597 |
ROPARGYL-DOTA-TRIS(TBU)ESTER;基于NOTADOTA定制和偶联 |
129 |
zcy |
2024-11-29 |
82598 |
降冰片烯官能化聚丙烯酸叔丁酯(NB-PtBA) |
159 |
h |
2024-11-29 |
82599 |
聚降冰片烯纳米纤维(PNB) |
251 |
h |
2024-11-29 |
82600 |
TRI-TERT-BUTYL 1,4,7,10-TETRAAZACYCLODOD;三叔丁基-1,4,7,10-四氮杂环十二烷 |
134 |
zcy |
2024-11-29 |
82601 |
DOTA-3-酪氨酰基-奥曲肽(DOTA-3-Tyr-Octreotide) |
79 |
zcy |
2024-11-29 |
82602 |
94885-02-6, C6 NBD Ceramide |
147 |
kx |
2024-11-29 |
82603 |
DOTA-tris(TBE)-amido dPEG (R)11-Maleimide;基于NOTADOTA定制和偶联 |
152 |
zcy |
2024-11-29 |
82604 |
479081-06-6 , DOTA-(COOt-Bu)3-NHFmoc-Lys |
180 |
wyh |
2024-11-29 |
82605 |
DOTA-octreotide |
89 |
wyh |
2024-11-29 |
82606 |
CAS:127985-74-4 ,DOTA-p-NCS-Bn ,多肽标记的双功能螯合剂 |
222 |
wyh |
2024-11-29 |
82607 |
N-(2-溴代异丁酰溴基)-顺-5-降冰片烯-外-2,3-二甲酰亚胺(exo-BNDI) |
161 |
h |
2024-11-29 |
82608 |
cyclo(RGDFK(DOTA)) |
115 |
wyh |
2024-11-29 |
82609 |
DOTA-tris(acid)-amido-dPEG (R)24-amido-dPEG (R)24-DSPE 定制 |
165 |
zcy |
2024-11-29 |
82610 |
Lu-DOTA-TATE ;镥-大环配体-TATE多肽 |
134 |
wyh |
2024-11-29 |
82611 |
11,12-二脱氢-ε-氧代二苯并[b,f]氮杂环辛-5(6H)-己酸,DBCO-C6-acid |
128 |
kx |
2024-11-29 |
82612 |
降冰片烯改性聚乙烯醇(PVA) |
201 |
h |
2024-11-29 |
82613 |
DOTA-PEG-CPP , DOTA-聚乙二醇-酪蛋白磷酸肽 |
152 |
wyh |
2024-11-29 |
82614 |
乙酰基保护的降冰片烯含异类糖单体NBManGluOAc |
128 |
h |
2024-11-29 |
82615 |
降冰片二烯二酸单甲酯(NBD-COOH) |
233 |
h |
2024-11-29 |
82616 |
DOTA-E「cyclo(RGDfK)2的结构组成 |
171 |
wyh |
2024-11-29 |
82617 |
Ho-p-SCN-Bn-DOTA;2126179-28-8;基于NOTADOTA定制和偶联 |
98 |
zcy |
2024-11-29 |
82618 |
十八烷基-聚乙二醇-巯基吡啶 OPSS-PEG-C18 |
93 |
zyl |
2024-11-29 |
82619 |
DOTA-(Tyr3)-Octreotate,大环配体修饰多肽 |
103 |
wyh |
2024-11-29 |
82620 |
(S,R,S)-AHPC-Me-C6-NH2,CAS号:2411422-49-4 |
86 |
zyl |
2024-11-29 |